[1]Berry M, Ahmed Z, Morgan-Warren P, et al. Prospects for mTOR-mediated functional repair after central nervous system trauma[J]. Neurobiol Dis,2016, 85: 99-110.
[2]Luo M, Hu ZhX, Liang DM. Derivation of neuroglia progenitors from human embryonic stem cells in feeder layer-and serum-free medium[J]. Acta Anatomica Sinica, 2011, 42(2): 279-282. (in Chinese)
罗敏,胡智兴,梁道明. 无血清无饲养层人胚胎干细胞向胶质前体细胞的分化[J]. 解剖学报,2011, 42(2): 279-282.
[3]Kirby L, Jin J, Cardona JG, et al. Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination[J]. Nat Commun, 2019, 10(1): 3887.
[4]Zhang P, Kishimoto Y, Grammatikakis I, et al. Senolytic therapy alleviates abeta-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer’s disease model [J]. Nat Neurosci, 2019, 22(5): 719-728.
[5]Ma H, Wert KJ, Shvartsman D, et al. Establishment of human pluripotent stem cell-derived pancreatic beta-like cells in the mouse pancreas[J]. Proc Natl Acad Sci USA, 2018, 115(15): 3924-3929.
[6]Dietz KC, Polanco JJ, Pol SU, et al. Targeting human oligodendrocyte progenitors for myelin repair [J]. Exp Neurol, 2016, 283(Pt B): 489-500.
[7]Bacakova L, Zarubova J, Travnickova M, et al. Stem cells: their source, potency and use in regenerative therapies with focus on adipose-derived stem cells-a review[ J]. Biotechnol Adv, 2018, 36(4): 1111-1126.
[8]Ju XJ, Niu YY, Rao LB, et al. Experiment of the differentiation of adipose-derived stem cells into fibroblasts[J].Acta Anatomica Sinica,2020, 51(4): 513-519. (in Chinese)
鞠晓军,牛友芽,饶利兵,等. 脂肪源性干细胞向成纤维细胞的分化[J]. 解剖学报,2020, 51(4): 513-519.
[9]Barateiro A, Brites D, Fernandes A. Oligodendrocyte development and myelination in neurodevelopment: molecular mechanisms in health and disease[J]. Curr Pharm Des, 2016, 22(6):656-679.
[10] Hoftberger R, Lassmann H. Inflammatory demyelinating diseases of the central nervous system [J]. Handb Clin Neurol, 2017, 145: 263-283.
[11] Plemel JR, Liu WQ, Yong VW. Remyelination therapies: a new direction and challenge in multiple sclerosis [J]. Nat Rev Drug Discov, 2017, 16(9):617-634.
[12] Franklin RJM, Ffrench-Constant C. Remyelination in the CNS: from biology to therapy [J]. Nat Rev Neurosci, 2008, 9(11): 839-855.
[13] Wang G, Ding L, Gao C, et al. Neuroprotective effect of l-serine against white matter demyelination by harnessing and modulating inflammation in mice [J]. Neuropharmacology, 2019, 146: 39-49.
[14] Jkel S, Agirre E, Mendanha Falco A, et al. Altered human oligodendrocyte heterogeneity in multiple sclerosis [J]. Nature, 2019, 566(7745): 543-547.
[15] Tokunaga H, Seiwa C, Yoshioka N, et al. An Extract of chinpi, the dried peel of the citrus fruit unshiu, enhances axonal remyelination via promoting the proliferation of oligodendrocyte progenitor cells[J]. Evid Based Complement Alternat Med, 2016, 2016: 8692698.
[16] Levine JM, Reynolds R, Fawcett JW. The oligodendrocyte precursor cell in health and disease[J]. Trends Neurosci, 2001, 24(1): 39-47.
[17] Osorio MJ, Goldman SA. Glial progenitor cell-based treatment of the childhood leukodystrophies [J]. Exp Neurol, 2016, 283(Pt B): 476-488.
[18] Wang C, Luan Z, Yang Y, et al. High purity of human oligodendrocyte progenitor cells obtained from neural stem cells: suitable for clinical application[J]. J Neurosci Methods, 2015, 240: 61-66.
[19] Sugaya K, Vaidya M. Stem cell therapies for neurodegenerative diseases [J]. Adv Exp Med Biol, 2018, 1056: 61-84.
[20] Fraser J, Wulur I, Alfonso Z, et al. Differences in stem and progenitor cell yield in different subcutaneous adipose tissue depots[J]. Cytotherapy, 2007, 9(5): 459-467.
[21] Prunet-Marcassus B, Cousin B, Caton D, et al. From heterogeneity to plasticity in adipose tissues: site-specific differences [J]. Exp Cell Res, 2006, 312(6): 727-736.
[22] Cheng NC, Lin WJ, Ling TY, et al. Sustained release of adipose-derived stem cells by thermosensitive chitosan/gelatin hydrogel for therapeutic angiogenesis[J]. Acta Biomater, 2017, 51: 258-267.
[23] Huang Q, Zou Y, Arno MC, et al. Hydrogel scaffolds for differentiation of adipose-derived stem cells[J]. Chem Soc Rev, 2017, 46(20): 6255-6275.
[24] Ilyasov AA, Milligan CE, Pharr EP, et al. The endocannabinoid system and oligodendrocytes in health and disease [J]. Front Neurosci, 2018, 12: 733.
[25] Dimou L, Gallo V. NG2-glia and their functions in the central nervous system[J]. Glia, 2015, 63(8): 1429-1451.
|